Twist Bioscience Corporation TWST Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| DNA synthesis and protein solutions | $93.78M+361% | $20.33M-12.3% | $23.17M-4.1% | $24.17M+246% | |
| NGS applications | $208.1M+23.0% | $169.13M+36.7% | $123.71M+24.6% | $99.31M+36.7% | |
| Revenue by Geography | |||||
| Americas | $225.58M+16.3% | $193.88M+28.2% | $151.26M+24.3% | $121.7M+56.2% | |
| APAC | $26.75M+0.9% | $26.52M+18.1% | $22.46M+18.6% | $18.94M+83.9% | |
| EMEA | $124.24M+34.2% | $92.57M+29.7% | $71.39M+13.5% | $62.92M+42.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Twist Bioscience Corporation break its business down?
- Twist Bioscience Corporation (TWST) reports revenue by product across 2 parts — DNA synthesis and protein solutions and NGS applications. Each is extracted from the segment footnotes and tracked over time.
- Where does Twist Bioscience Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Twist Bioscience Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
